Dark chemical matter as a promising starting point for drug lead discovery

Anne Mai Wassermann; Eugen Lounkine; Dominic Hoepfner; Gaëlle Le Goff; Frederick J. King; Christian Studer; John M. Peltier; Melissa L Grippo; Vivian Prindle; Jianshi Tao; Ansgar Schuffenhauer; Iain M. Wallace; Shanni Chen; Philipp Krastel; Amanda Cobos‐Correa; Christian N. Parker; John W. Davies; Meir Glick

doi:10.1038/nchembio.1936

Keywords

Drug discoveryChemical spaceComputational biologyHigh-throughput screeningAntifungalDrugChemotypeSmall moleculeChemical geneticsBiologyChemistryPharmacologyBioinformaticsBiochemistryMicrobiology

Affiliated Institutions

Related Publications

PocketQuery: protein-protein interaction inhibitor starting points from protein-protein interaction structure

David Ryan Koes , Carlos J. Camacho

PocketQuery (http://pocketquery.csb.pitt.edu) is a web interface for exploring the properties of protein-protein interaction (PPI) interfaces with a focus on the discovery of pr...

2012 Nucleic Acids Research 89 citations

Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning

Sigrid A. Langhans

Drug development is a lengthy and costly process that proceeds through several stages from target identification to lead discovery and optimization, preclinical validation and c...

2018 Frontiers in Pharmacology 1449 citations

<i>In silico</i>pharmacology for drug discovery: applications to targets and beyond

Sean Ekins , Jordi Mestres , Bernard Testa

Computational ( in silico ) methods have been developed and widely applied to pharmacology hypothesis development and testing. These in silico methods include databases, quantit...

2007 British Journal of Pharmacology 343 citations

DrugBank: a comprehensive resource for in silico drug discovery and exploration

David S. Wishart

DrugBank is a unique bioinformatics/cheminformatics resource that combines detailed drug (i.e. chemical) data with comprehensive drug target (i.e. protein) information. The data...

2005 Nucleic Acids Research 3895 citations

An Integrated in Silico 3D Model-Driven Discovery of a Novel, Potent, and Selective Amidosulfonamide 5-HT<sub>1A</sub> Agonist (PRX-00023) for the Treatment of Anxiety and Depression

Oren M. Becker , Dale Dhanoa , Yael Marantz +10 more

We report the discovery of a novel, potent, and selective amidosulfonamide nonazapirone 5-HT1A agonist for the treatment of anxiety and depression, which is now in Phase III cli...

2006 Journal of Medicinal Chemistry 139 citations

Publication Info

Year: 2015
Type: article
Volume: 11
Issue: 12
Pages: 958-966
Citations: 132
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Dark chemical matter as a promising starting point for drug lead discovery

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

132

OpenAlex

Cite This

APA Style

                            
                                
                                    Anne Mai Wassermann, 
                                
                                    Eugen Lounkine, 
                                
                                    Dominic Hoepfner
                                
                                et al.
                            
                            (2015). 
                            Dark chemical matter as a promising starting point for drug lead discovery. 
                            Nature Chemical Biology
                            , 11
                            (12)
                            , 958-966.
                            https://doi.org/10.1038/nchembio.1936
                        

Identifiers

DOI: 10.1038/nchembio.1936